Bluejay Diagnostics Statistics
Share Statistics
Bluejay Diagnostics has 552.85K shares outstanding. The number of shares has increased by -55.38% in one year.
| Shares Outstanding | 552.85K |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -96.66% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 551.23K |
| Failed to Deliver (FTD) Shares | 6.38K |
| FTD / Avg. Volume | 0.92% |
Short Selling Information
The latest short interest is 159.88K, so 28.92% of the outstanding shares have been sold short.
| Short Interest | 159.88K |
| Short % of Shares Out | 28.92% |
| Short % of Float | 29.01% |
| Short Ratio (days to cover) | 0.09 |
Valuation Ratios
The PE ratio is -6.72 and the forward PE ratio is -0.34.
| PE Ratio | -6.72 |
| Forward PE | -0.34 |
| PS Ratio | 0 |
| Forward PS | 0.2 |
| PB Ratio | 23.11 |
| P/FCF Ratio | -7.42 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Bluejay Diagnostics Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.82 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0.12 |
| Total Debt / Capitalization | 10.87 |
| Cash Flow / Debt | -23.55 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -3.44% and return on capital (ROIC) is -317.48%.
| Return on Equity (ROE) | -3.44% |
| Return on Assets (ROA) | -2.04% |
| Return on Capital (ROIC) | -317.48% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -995.39K |
| Employee Count | 10 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -99.16% in the last 52 weeks. The beta is 0.73, so Bluejay Diagnostics 's price volatility has been higher than the market average.
| Beta | 0.73 |
| 52-Week Price Change | -99.16% |
| 50-Day Moving Average | 4.12 |
| 200-Day Moving Average | 75.1 |
| Relative Strength Index (RSI) | 42.4 |
| Average Volume (20 Days) | 690.10K |
Income Statement
| Revenue | n/a |
| Gross Profit | -780.96K |
| Operating Income | -10.31M |
| Net Income | -9.95M |
| EBITDA | -9.17M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -72.62 |
Balance Sheet
The company has 2.21M in cash and 352.98K in debt, giving a net cash position of 1.86M.
| Cash & Cash Equivalents | 2.21M |
| Total Debt | 352.98K |
| Net Cash | 1.86M |
| Retained Earnings | -26.95M |
| Total Assets | 8.35M |
| Working Capital | 5.52M |
Cash Flow
In the last 12 months, operating cash flow was -8.31M and capital expenditures -704.17K, giving a free cash flow of -9.02M.
| Operating Cash Flow | -8.31M |
| Capital Expenditures | -704.17K |
| Free Cash Flow | -9.02M |
| FCF Per Share | -65.8 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BJDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2135.88% |
| FCF Yield | -479.76% |
Analyst Forecast
Currently there are no analyst rating for BJDX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 18, 2024. It was a backward split with a ratio of 1:50.
| Last Split Date | Nov 18, 2024 |
| Split Type | backward |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | -6.52 |
| Piotroski F-Score | 2 |